ClinicalTrials.Veeva

Menu
A

AppleMed Research Group, LLC | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rimegepant
Vibegron
Dihydroergotamine
Tolterodine
Zavegepant
Lorecivivint
casirivimab+imdevimab
ARO-APOC3
Tolterodine Tartrate
BHV-2100

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 20 total trials

A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the...

Enrolling
Knee Osteoarthritis
Biological: Amniotic Suspension Allograft
Drug: Placebo

The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatmen...

Active, not recruiting
Migraine
Drug: Placebo comparator dosing
Drug: Rimegepant 75mg every other day dosing

This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treat...

Enrolling
Migraine
Drug: Placebo
Drug: BHV-2100

This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medic...

Enrolling
Migraine
Drug: Rimegepant
Drug: Placebo

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate...

Enrolling
Migraine
Drug: Placebo
Drug: Rimegepant

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18...

Enrolling
Acute Treatment of Migraine
Drug: Rimegepant (PF-07899801)

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling
Pediatric Migraine
Drug: Rimegepant/BHV3000
Drug: Matching placebo

Trial sponsors

Pfizer logo
S
U
Arrowhead Pharmaceuticals logo
Biohaven logo
B
Boehringer Ingelheim logo
Dr.Reddy's Laboratories logo
MiMedx logo
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems